Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus
Top Cited Papers
Open Access
- 29 June 2011
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 108 (29), 12018-12023
- https://doi.org/10.1073/pnas.1107024108
Abstract
Human pandemic H1N1 2009 influenza virus rapidly infected millions worldwide and was associated with significant mortality. Antiviral drugs that inhibit influenza virus replication are the primary therapy used to diminish disease; however, there are two significant limitations to their effective use: (i) antiviral drugs exert selective pressure on the virus, resulting in the generation of more fit viral progeny that are resistant to treatment; and (ii) antiviral drugs do not directly inhibit immune-mediated pulmonary injury that is a significant component of disease. Here we show that dampening the host9s immune response against influenza virus using an immunomodulatory drug, AAL-R, provides significant protection from mortality (82%) over that of the neuraminidase inhibitor oseltamivir alone (50%). AAL-R combined with oseltamivir provided maximum protection against a lethal challenge of influenza virus (96%). Mechanistically, AAL-R inhibits cellular and cytokine/chemokine responses to limit immunopathologic damage, while maintaining host control of virus replication. With cytokine storm playing a role in the pathogenesis of a wide assortment of viral, bacterial, and immunologic diseases, a therapeutic approach using sphingosine analogs is of particular interest.Keywords
This publication has 44 references indexed in Scilit:
- Cytokine-dependent but acquired immunity-independent arthritis caused by DNA escaped from degradationProceedings of the National Academy of Sciences, 2010
- Reassortment of Pandemic H1N1/2009 Influenza A Virus in SwineScience, 2010
- The Transmissibility and Control of Pandemic Influenza A (H1N1) VirusScience, 2009
- S1P3-mediated cardiac fibrosis in sphingosine kinase 1 transgenic mice involves reactive oxygen speciesCardiovascular Research, 2009
- In vitro and in vivo characterization of new swine-origin H1N1 influenza virusesNature, 2009
- Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus InfectionsJournal of Virology, 2009
- A critical role for the sphingosine analog AAL-R in dampening the cytokine response during influenza virus infectionProceedings of the National Academy of Sciences, 2009
- Local Not Systemic Modulation of Dendritic Cell S1P Receptors in Lung Blunts Virus-Specific Immune Responses to InfluenzaMolecular Pharmacology, 2008
- Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virusProceedings of the National Academy of Sciences, 2008
- The Pathology of Influenza Virus InfectionsAnnual Review Of Pathology-Mechanisms Of Disease, 2008